/ /

Tracey Walker
Why there’s an uptick in outcomes-based contracts
Operational issues aside, outcomes-based contracts can offer a two-fold benefit for managed care executives.
Can Amazon change the pharmacy landscape?
Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Top ACA provisions employers want to keep
A Willis Towers Watson survey finds that employers see enhancing the employee experience in healthcare as key to boosting health engagement.
Top 3 strategies employers should use to decrease healthcare costs
A new Willis Towers Watson survey finds that U.S. employers have three key strategies to building cost-effective healthcare programs. 
Robust multiple myeloma treatment program holds promise
The Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Are non-opioid therapies more desirable than opioids for chronic pain?
A new study from researchers from the Minneapolis VA Health Care System has interesting findings.
Innovative strategies help fight multiple myeloma: What every exec should know
As new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Patients who need PCSK9 inhibitors cant get them
Study: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.
Here’s why preventive care should be a priority
A Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.
Hep C drugs could increase Medicare Part D spending by 11% in 2015
If 15% to 30% of HCV-infected beneficiaries receive treatment in 2015 with the cost of treatment averaging $84,000, Medicare Part D could increase between $2.9 billion and $5.8 billion